Rudolf M. Huber

15.3k citations

221 papers · 5.4k indexed · 1 hit paper · h-index 38

Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 75
- Lung Cancer Diagnosis and Treatment 58
- Chronic Obstructive Pulmonary Disease (COPD) Research 23
- Tracheal and airway disorders 16
Oncology top 1%
- Lung Cancer Research Studies 49
- Cancer Immunotherapy and Biomarkers 16
Cancer Research top 5%
Genetics top 5%
Physiology top 5%
- Asthma and respiratory diseases 21
Epidemiology
- Neuroendocrine Tumor Research Advances 14

Co-authors: Amanda Tufman Hŭbert Haŭtmann Fernando Gamarra Albrecht Bergner Rainald Fischer Markus O. Henke Diego Kauffmann‐Guerrero Jorg Schönherr
Cited by: Pulmonary and Respiratory Medicine Oncology Cancer Research
Journals: Journal of Clinical Oncology (19 papers)SHILAP Revista de lepidopterología (1 paper)Nature Biotechnology (1 paper)
Partner nations: Germany United States Austria

In The Last Decade

Rudolf M. Huber

207 papers receiving 5.3k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Rudolf M. Huber

Since Specialization

Citations

This map shows the geographic impact of Rudolf M. Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudolf M. Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudolf M. Huber more than expected).

Fields of papers citing papers by Rudolf M. Huber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rudolf M. Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudolf M. Huber. The network helps show where Rudolf M. Huber may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rudolf M. Huber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rudolf M. Huber Line = papers co-authored together Rudolf M. Huber links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Resectable non-stage IV nonsmall cell lung cancer: the surgical perspective European Respiratory Review ·Clemens Aigner,Hasan Fevzi Batırel,Rudolf M. Huber,David R. Jones,Alan Sihoe,Tomaž Štupnik,Alessandro Brunelli	2024	1
2	Brigatinib in ALK+ NSCLC pts with intracranial CNS metastases in 2 clinical trials Annals of Oncology ·Marcello Tiseo,Rudolf M. Huber,Maximilian J. Hochmair,Lyudmila Bazhenova,S.-H.I. Ou,William M. Reichmann,J. Haney,David Kerstein,D. Ross Camidge,Scott Gettinger	2017	2
3	Perception of climate change in patients with chronic lung disease PLoS ONE ·Jeremias Götschke,Pontus Mertsch,Michael Bischof,Nikolaus Kneidinger,Sandhya Matthes,Ellen D. Renner,Konrad Schultz,Claudia Traidl‐Hoffmann,Hans‐Werner Duchna,Jürgen Behr,Jürgen Schmude,Rudolf M. Huber,Katrin Milger	2017	7
4	Interactions among Lung Cancer Cells, Fibroblasts, and Macrophages in 3D Co-Cultures and the Impact on MMP-1 and VEGF Expression PLoS ONE ·Xiaoqing Liu,Rosemarie Kiefl,Claudia C. Roskopf,Fei Tian,Rudolf M. Huber	2016	42
5	Screening colonoscopy in adults with cystic fibrosis European Respiratory Journal ·Susanne Naehrig,Rudolf M. Huber,Veit Gülberg,Jürgen Behr	2014	0
6	Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients with Brain Metastases or Leptomeningeal Disease Journal of Thoracic Oncology ·Petra Hoffknecht,Amanda Tufman,Thomas Wehler,Theo Pelzer,Rainer Wiewrodt,Martin Schütz,Monika Serke,Jan Stöhlmacher-Williams,Angela Märten,Rudolf M. Huber,Nicolas Dickgreber	2014	217
7	Feasibility of microRNA Measurements in Routine Bronchoalveolar Lavage (BAL) and Bronchial Washings in Patients With Lung Cancer and Nonmalignant Pulmonary Diseases CHEST Journal ·Amanda Tufman,Fernando Gamarra,Rosi Kiefl,Sajo Kaduthanam,Ruprecht Kuner,Rudolf M. Huber	2014	1
8	Interleukin-22 Is Frequently Expressed in Small- and Large-Cell Lung Cancer and Promotes Growth in Chemotherapy-Resistant Cancer Cells Journal of Thoracic Oncology ·Sebastian Kobold,Stefanie Völk,Till S. Clauditz,Natascha Jennifer Küpper,Sarah Minner,Amanda Tufman,P Düwell,Michael Lindner,Ina Koch,Simon Heidegger,Simon Rothenfußer,Max Schnurr,Rudolf M. Huber,Waldemar Wilczak,Stefan Endres	2013	53
9	Spirometric Reference Values for Advanced Age from a South German Population Respiration ·Stefan Karrasch,Claudia Flexeder,Jürgen Behr,Rolf Holle,Rudolf M. Huber,Rudolf A. Jörres,Dennis Nowak,Annette Peters,H.‐Erich Wichmann,Joachim Heinrich,Holger Schulz,(unknown)	2012	10
10	Effects of the Hedgehog pathway inhibitor GDC-0449 on lung cancer cell lines are mediated by side populations Clinical and Experimental Medicine ·Fei Tian,Josef Mysliwietz,Joachim W. Ellwart,Fernando Gamarra,Rudolf M. Huber,Albrecht Bergner	2011	52
11	Exhaled nitric oxide and influencing factors in a random population sample Respiratory Medicine ·Stefan Karrasch,Kathrin Ernst,Jürgen Behr,Joachim Heinrich,Rudolf M. Huber,Dennis Nowak,H-Erich Wichmann,Sebastian E. Baumeister,Christa Meisinger,Karl‐Heinz Ladwig,Rolf Holle,Rudolf A. Jörres,Holger Schulz	2010	22
12	Concurrent Chemoradiation Therapy With Docetaxel/Cisplatin Followed by Docetaxel Consolidation Therapy in Inoperable Stage IIIA/B Non–Small-Cell Lung Cancer: Results of a Phase I Study Clinical Lung Cancer ·Rudolf M. Huber,Astrid Borgmeier,Michael Flentje,Jochen Willner,Michael Schmidt,Christian Manegold,Peter Bramlage,Jürgen Debus	2010	4
13	Geriatrische Assessments und Diagnostik beim älteren Patienten Onkologie ·Karl-Matthias Deppermann,Christoph Friedrich,Felix Herth,Rudolf M. Huber	2008	4
14	IL-13Rα2 Reverses the Effects of IL-13 and IL-4 on Bronchial Reactivity and Acetylcholine-Induced Ca<sup>2+</sup> Signaling International Archives of Allergy and Immunology ·Julia Kellner,Fernando Gamarra,Ulrich Welsch,Rudolf A. Jörres,Rudolf M. Huber,Albrecht Bergner	2006	27
15	Lungenkarzinom Der Internist ·Rudolf M. Huber	2006	1
16	Improvement of Alveolar Glutathione and Lung Function but Not Oxidative State in Cystic Fibrosis American Journal of Respiratory and Critical Care Medicine ·Matthias Griese,Jan Ramakers,Angela I Krasselt,Vitaliy Starosta,Silke van Koningsbruggen,Rainald Fischer,Félix Ratjen,B Müllinger,Rudolf M. Huber,Konrad Maier,Ernst Rietschel,G. Scheuch	2004	84
17	Early detection and prevention of lung cancer European Respiratory Review ·Kristiaan Nackaerts,Élisabeth Brambilla,Nico van Zandwijk,Katja Bromen,Stefan Diederich,Fred R. Hirsch,Rudolf M. Huber,Vincent Ninane,Francesco Leo,Luc Thiberville,Olav Axelson,Maurits Demedts,Benoît Nemery,Michel Petit,Stephen Spiro,Annie J. Sasco,Jan P. van Meerbeeck	2002	2
18	Combined transcriptome and genome analysis of single micrometastatic cells Nature Biotechnology ·Christoph A. Klein,Stefan Seidl,Karina Petat‐Dutter,Sonja Offner,Jochen B. Geigl,Oleg Schmidt‐Kittler,Nicole Wendler,Bernward Passlick,Rudolf M. Huber,Günter Schlimok,Patrick A. Baeuerle,Gert Riethmüller	2002	234
19	Impaired Rapid Mineralocorticoid Action on Free Intracellular Calcium in Pseudohypoaldosteronism¹ The Journal of Clinical Endocrinology & Metabolism ·Fernando Gamarra,Gunter Ŝimić-Schleicher,Rudolf M. Huber,Axel Ulsenheimer,Peter Christian Scriba,Ursula Kuhnle,Martin Wehling	1997	7
20	Growth-hormone releasing hormone in a bronchial carcinoid Cancer ·Rudolf M. Huber,Jochen Schopohl,Marco Losa,G Wolfram,O. Thetter,Willibald Permanetter,Klaus von Werder	1991	10

About Rudolf M. Huber

Rudolf M. Huber is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology, having authored 221 papers that have together received 5.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (75 papers), Lung Cancer Diagnosis and Treatment (58 papers), Lung Cancer Research Studies (49 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (23 papers), Asthma and respiratory diseases (21 papers), Cancer Immunotherapy and Biomarkers (16 papers), Tracheal and airway disorders (16 papers) and Neuroendocrine Tumor Research Advances (14 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.3k citations), Oncology (1.8k citations) and Cancer Research (484 citations). Rudolf M. Huber has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Amanda Tufman, Hŭbert Haŭtmann, Fernando Gamarra, Albrecht Bergner, Rainald Fischer, Markus O. Henke, Diego Kauffmann‐Guerrero, Jorg Schönherr, Kathrin Kahnert and Rudolf A. Jörres. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact